1996
DOI: 10.1002/(sici)1097-0142(19960201)77:3<467::aid-cncr7>3.0.co;2-h
|View full text |Cite
|
Sign up to set email alerts
|

Malignant mesenchymoma

Abstract: Malignant mesenchymoma represents a particularly aggressive form of soft tissue sarcoma. Our experience with this disease highlights the need for more effective treatment strategies for these patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
16
0
3

Year Published

2001
2001
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(19 citation statements)
references
References 9 publications
0
16
0
3
Order By: Relevance
“…22,25 The term 'malignant mesenchymoma' has been applied to sarcomas that exhibited two or more lines of specialized differentiation. [10][11][12] In spite of strict diagnostic criteria, the existence of malignant mesenchymoma remains controversial and in the latest WHO classification on soft tissue tumors was not regarded as a distinct clinicopathologic entity. 26 Dedifferentiated liposarcoma may exhibit heterologous differentiation in about 5% of cases, mainly with osteo-/chondro-sarcoma or myosarcomatous elements.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…22,25 The term 'malignant mesenchymoma' has been applied to sarcomas that exhibited two or more lines of specialized differentiation. [10][11][12] In spite of strict diagnostic criteria, the existence of malignant mesenchymoma remains controversial and in the latest WHO classification on soft tissue tumors was not regarded as a distinct clinicopathologic entity. 26 Dedifferentiated liposarcoma may exhibit heterologous differentiation in about 5% of cases, mainly with osteo-/chondro-sarcoma or myosarcomatous elements.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the distinction between dedifferentiated liposarcoma showing heterologus components, 8,9 such as osteosarcoma-like morphology, 8 and malignant mesenchymoma characterized by the coexistence of well-differentiated liposarcoma and osteosarcoma still remains obscure. [10][11][12] Therefore, the aim of current series was to better address the aforementioned questions by correlating the morphological variations, extent, and histological grades of dedifferentiation with the clinical evolution, preferential metastatic sites, and postmetastatic survival of seven patients developing distant metastasis from their retroperitoneal dedifferentiated liposarcoma.…”
mentioning
confidence: 99%
“…Bradythe et al reported in eight femoral and retroperitoneal cases that the survival rates for 2-3 years were 75% and 37%, respectively. [9] However, in a research conducted by Newman, Fletcher et al on six cases, low-grade malignant behavior was identified in these tumors and the follow-up period of four of these cases was <5 years. [10] Adachia et al determined that the presence of the rhabdomyosarcomas component and patients aged 40 years had bad prognosis and that sex, tumor area, tumor size or the MIB-1 classification index findings did not have an impact on the prognosis.…”
Section: Case Reportmentioning
confidence: 99%
“…Terminolojik olarak daha çok heterolog farklanma gösteren leiomyosarkom terimi kullanılmaktadır. En sık görü-len birlikteliği rabdomyosarkom-liposarkom veya rabdomyosarkom-osteo/kondrosarkomdur 3,4 . Tü-mörün en sık yerleşim yeri retroperiton olmakla birlikte, farklı lokalizasyonlarda da geliştiği bildirilmiştir.…”
Section: Introductionunclassified